XNNHQ Xenonics Holdings Inc (CE)

XENONICS HOLDINGS, INC. (OTCQB:XNNH) today announced financial results for the second quarter and first six months of fiscal 2014.

Revenue for the three months ended March 31, 2014 decreased to $16,000. This compares to revenue of $961,000 for the second quarter of fiscal 2013. The net loss for this year's second quarter was $576,000, or $0.02 per basic and diluted share. This compares to a net loss for the second quarter of fiscal 2013 of $293,000, or $0.01 per basic and diluted share.

For the six months ended March 31, 2014, revenue decreased to $79,000 compared to $1,118,000 for last year's first half. The net loss for the first six months of fiscal 2014 was $1,179,000, or $0.05 per basic and diluted share. This compares to a net loss for the first six months of fiscal 2013 of $787,000, or $0.03 per basic and diluted share.

"Approximately $250,000 of orders we had expected to ship in the second quarter were shipped in the third quarter instead. We continue to expect additional significant orders from military and international customers. We currently are in the process of arranging additional financing to support our operations," said Chairman Alan Magerman.

Conference Call

Xenonics has scheduled a conference call at 11:00 a.m. EDT this morning to discuss its results for the quarter. To participate in the call, dial (800) 510-0146, passcode #16845774. A simultaneous webcast of the conference call can be accessed from the Webcast Center of the Investor Relations link at www.xenonics.com. A replay will be available after 1:00 p.m. EDT at this same Internet address. For a telephone replay, dial (888) 286-8010, passcode #92288381, after 2:00 p.m. EDT.

About Xenonics

Xenonics Holdings, Inc. develops and produces advanced, lightweight and compact ultra-high-intensity illumination and low-light vision products for military, law enforcement, public safety, and commercial and private sector applications. Xenonics' NightHunter line of illumination products is used by every branch of the U.S. Armed Forces as well as law enforcement and security agencies. Its SuperVision high-definition night vision is designed for commercial and military applications. Employing patented technologies, Xenonics provides innovative solutions for customers who must see farther so they can do their jobs better and safer. Xenonics' products represent the next generation in small, high intensity, high efficiency illumination and low-light vision systems. Visit Xenonics on the web at www.xenonics.com.

Forward-Looking Statements

Except for the historical statements, statements in this release may constitute forward-looking statements within the meaning of section 21E of the Securities Exchange Act of 1934. When used, the words "anticipates," "believes," "expects," "intends," "future," and other similar expressions identify forward-looking statements. These forward-looking statements reflect management's current views with respect to future events and financial performance and are subject to risks and uncertainties, and actual results may differ materially from the outcomes contained in any forward-looking statement. Factors that could cause these forward-looking statements to differ from actual results include delays in development, marketing or sales of new products, and other risks and uncertainties discussed in the company's periodic reports on Form 10-K and 10-Q and other filings with the Securities and Exchange Commission. Xenonics Holdings undertakes no obligation to update or revise any forward-looking statements.

 

XENONICS HOLDINGS, INC

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 

 

 

 

 

 

 

 

Three months ended

 

Six months ended

 

March 31,

 

March 31,

 

 

2014

 

 

 

2013

 

 

 

2014

 

 

 

2013

 

Rounded to the nearest thousand, except per share amounts

(unaudited)

 

(unaudited)

 

 

 

 

Revenues

$

16,000

 

$

961,000

 

$

79,000

 

$

1,118,000

 

 

 

 

Cost of goods sold

 

6,000

 

 

 

505,000

 

 

 

44,000

 

 

 

580,000

 

 

 

 

 

Gross profit

10,000

 

456,000

 

35,000

 

538,000

 

 

 

 

Selling, general and administrative

384,000

 

468,000

 

799,000

 

884,000

Research and development

 

101,000

 

 

 

108,000

 

 

 

229,000

 

 

 

227,000

 

 

 

 

 

Income (loss) from operations

(475,000

)

 

(120,000

)

 

(993,000

)

 

(573,000

)

 

 

 

 

 

 

 

 

Other income/(expense):

 

 

 

 

 

 

 

Interest (expense)

 

(101,000

)

 

 

(173,000

)

 

 

(184,000

)

 

 

(212,000

)

 

 

 

 

Income (loss) before provision for income taxes

(576,000

)

 

(293,000

)

 

(1,177,000

)

 

(785,000

)

Income tax provision

 

--

 

 

 

--

 

 

 

2,000

 

 

 

2,000

 

 

 

 

 

Net income (loss)

$

(576,000

)

 

$

(293,000

)

 

$

(1,179,000

)

 

$

(787,000

)

 

 

 

 

 

 

 

 

Net income (loss) per share:

 

 

 

 

 

 

 

Basic and fully-diluted

$

(0.02

)

 

$

(0.01

)

 

$

(0.05

)

 

$

(0.03

)

 

 

 

 

Weighted average shares outstanding:

 

 

 

 

 

 

 

Basic and fully-diluted

 

24,976,000

 

 

 

24,976,000

 

 

 

24,976,000

 

 

 

24,976,000

     

XENONICS HOLDINGS, INC

CONDENSED CONSOLIDATED BALANCE SHEETS         March 31, September 30,   2014     2013   Rounded to the nearest thousand, except par value (unaudited)   Assets   Current Assets: Cash $ 4,000 $ 220,000 Accounts receivable 1,000 30,000 Inventories 1,121,000 1,154,000 Other current assets   35,000     27,000     Total Current Assets 1,161,000 1,431,000   Inventories 480,000 480,000 Equipment, furniture and fixtures at cost, net 7,000 11,000 Goodwill 375,000 375,000 Other assets   17,000     17,000     Total Assets $ 2,040,000   $ 2,314,000       Liabilities and Shareholders' Deficit   Current Liabilities: Accounts payable $ 591,000 $ 399,000 Accrued expenses 357,000 211,000 Accrued payroll and related taxes 168,000 91,000 Notes payable, net of debt discount   2,383,000     --     Total Current Liabilities 3,499,000 701,000   Notes payable   --     1,962,000     Total Liabilities   3,499,000     2,663,000     Commitments and contingencies   Shareholders' Deficit:

Preferred shares, $0.001 par value, 5,000,000 shares authorized, 0 shares issued and outstanding

-- --

Common shares, $0.001 par value, 50,000,000 shares authorized; 24,976,000 shares issued and outstanding at March 31, 2014 and September 30, 2013

25,000 25,000 Additional paid-in capital 26,947,000 26,879,000 Accumulated deficit   (28,431,000 )   (27,253,000 )   Total Shareholders' Deficit   (1,459,000 )   (349,000 )   Total Liabilities and Shareholders' Deficit $ 2,040,000   $ 2,314,000  

Company Contact:Xenonics Holdings, Inc.Alan Magerman, Chairman(760) 477-8900xenonics@xenonics.comorInvestor Contact:Berkman Associates(310) 477-3118info@BerkmanAssociates.com